Few studies have assessed if copy number gain or amplification in PIK3CA may be associated with response, however here, we observed that PIK3CA copy number gains are largely exclusive of single point mutations and may be higher in pre-treatment tumours which had residual disease at surgery. The gene discussed is PIK3CA; the disease is neoplasm.